Journal List > J Vet Sci > v.8(1) > 1041764

Lee, Kang, Kim, Bae, and Kim: Detection of swine hepatitis E virus in the porcine hepatic lesion in Jeju Island

Abstract

Swine hepatitis E virus (HEV) is an emerging zoonotic pathogen due to its close genomic similarity to human HEV. The prevalence of swine HEV in the hepatic lesion of pigs from the Jeju Island was investigated by reverse transcriptase polymerase chain reaction (RT-PCR). In total, 40 pigs with hepatitis lesions were selected from 19 different farms, based on examination by microscopy. RT-PCR findings revealed swine HEV in 22 cases (55%), including 18 suckling pigs and 4 growing pigs. Several histopathological lesions, including multifocal lymphoplasmacytic hepatitis, portal inflammation, and focal hepatocellular necrosis, were observed in liver sections of swine HEV PCR-positive pigs. The present study suggests that the prevalence of swine HEV is very high in the pig population in Jeju Island, and that pigs are infected at early stages of growth (under 2 months of age). The high prevalence of swine HEV in pigs in Jeju Island and the ability of this virus to infect across species puts people with swine-associated occupations at possible risk of zoonotic infection.

Introduction

Hepatitis E virus (HEV) is an enterically transmitted causative agent of acute non-A, non-B, and icterus-inducing hepatitis in humans [21]. HEV is a nonenveloped small virus with an approximately 7.5 kb single-stranded positive sense RNA genome containing 3 open reading frames. Based on its structural and physiochemical properties, HEV was provisionally classified as part of the family Caliciviridae, genus Calicivirus. Recently, the virus was reclassified in the genus Hepevirus of the novel family Hepeviridae [2]. The transmission of the virus into a host occurs primarily by a fecal-oral route via contaminated food or water. The course of this virus in humans is self-limiting, and chronic illness is not observed [21]. Clinical signs for hepatitis E infection include jaundice, anorexia, nausea, and hepatomegaly in young adults. The disease is slightly more severe than hepatitis A, but still induces low mortality in the general population (ranging from 0.2% to 4%). In particular, hepatitis E exerts severe effects in pregnant women, with high rates of fulminating hepatitis and increases in mortality of up to 20%, particularly during the third trimester [9].
An antibody to HEV has been identified in pigs both in developing countries, such as Nepal and Thailand, and industrialized countries, including the US, Canada, Korea, Taiwan, Spain, and Australia [3,5,15,18,25,27]. A novel swine HEV isolated from a pig in Illinois in 1997 was genetically related to 2 strains of human HEV isolates identified in the US, and cross-reacted with antibodies against the human HEV capsid protein [18]. Swine HEV has since been isolated in several countries in which hepatitis E is rare, including New Zealand, Spain, the Netherlands, Japan, Canada and Taiwan [6,10,20,23,27]. Cross-species infection has been experimentally demonstrated. Specifically, the US swine HEV isolate infected rhesus monkeys and a chimpanzee, while the US-2 strain of human HEV also infected pigs [8,17]. Thus, the pig may be an animal reservoir host for HEV, and its zoonotic or xenozoonotic potential is a significant health concern. HEV infection in pigs generally occurs at 2 to 3 months of age, and approximately 80 to 100% of pigs in the US and Japan are transiently infected [4,18,20,22,]. Infected pigs are not obviously ill, and display very mild liver lesions on histopathologic examination.
Three Korean isolates of swine HEV were initially identified in sera from 2- and 3-month old pigs [4]. A serological survey revealed that approximately 14.8% of swine sera and 17.7% of human sera were positive for HEV immunoglobulin G (IgG) on an enzyme-linked immunosorbent assay (ELISA). Korean HEV isolates from humans were genetically related to Korean swine isolates and human isolates previously identified in the US and Japan [1]. Immunohistochemical methods have been applied to detect swine HEV in formalin-fixed, paraffin-embedded hepatic tissues [7].
In this study, we sought to identify swine HEV in pig liver, and detect HEV antigens in hepatic lesions of pigs from Jeju Island, using reverse transcriptase-polymerase chain reaction.

Materials and Methods

Animal samples

In total, 40 pigs from 19 farms were selected on the basis of hepatitis lesions observed when examined by microscopy. The ages of the pigs ranged from 10 to 70 days. Of these, 33 were younger than 2 months of (suckling stage), and the other 7 were older than 2 months (growing stage). Negative control liver tissues were prepared from 1-day-old colostrum-deprived pigs in Jeju Island.

Tissue processing and histopathology

All liver samples were collected from pigs at necropsy. One-third of each liver was frozen at -70℃ for polymerase chain reaction (PCR), while the remaining part was fixed in 10% neutral buffered formalin for histopathology. After fixation, samples were embedded in paraffin wax using routine procedures, cut into 3 µm sections, and stained with hematoxylin and eosin.

Reverse transcriptase PCR

Reverse transcriptase (RT)-PCR was performed to detect viral RNA in liver tissue essentially as described previously [17]. Frozen samples were washed thoroughly with physiological saline until complete removal of blood. Four foci of liver samples (1 g) were homogenized with 10 ml DNase RNase free distilled water (Invitrogen, USA). Supernatant fractions were stored at -70℃ prior to use. RNA was extracted from 200 µl aliquots of supernatants using the RNeasy Protect Mini Kit (Qiagen, Germany). All liver samples were examined by nested PCR with primers constructed from the putative capsid gene (ORF2) region, as described previously [17]. First-round PCR produced an expected fragment of 404 base pairs (bp) with the forward primer F1 (5'-AGCTCCTGTACCTGATGTTGACTC-3') and the reverse primer R1 (5'-CTACAGAGCGCCAGCCTTGA TTGC-3'). Second-round PCR, performed with the forward primer F2 (5'-GCTCACGTCATCTGTCGCTGCTGG-3') and the reverse primer R2 (5'-GGGCTGAACCAAAATCCTG ACATC-3'), produced an expected fragment of 266 bp. All PCR analyses were performed on the Thermal Cycler Dice TP600 (TaKaRa, Japan). For RT-PCR, 2 µl RNA samples were added to 18 µl one step RT-PCR mixture (Maxime RT-PCR premix; iNtRON Biotechnology, Korea). One step RT-PCR and nested PCR were performed in keeping with previously established protocols [17]. Amplified products were visualized by staining with 0.5 µl/ml ethidium bromide on a 1.2% agarose gel.

Results

Gross findings and histopathological lesions

Typical gross lesions were not observed in any liver samples tested. Occasionally mild hepatic enlargement and scattered yellowish discoloration foci were observed in some samples (Fig. 1). Microscopically, mild to severe multifocal lymphoplasmacytic hepatitis was observed in 22 swine HEV PCR positive liver sections. In mild cases, we observed focal infiltration of lymphocytes, plasma cells, and macrophages in hepatic sinusoids and the portal triad (Fig. 2). Some hepatocytes and Kupffer cells were mildly swollen. Moderate to severe multifocal lymphoplasmacytic and histiocytic hepatitis or portal inflammation was noted in more severe cases (Fig. 3). In addition many oval cells were proliferated around bile ductular areas. Many hepatocytes displayed severe vacuolar degeneration and individual necrotic changes. Mild fatty change and focal hepatocellular necrosis were observed in some cases with no inflammatory reactions.

RT-PCR

For the detection of swine HEV, RT-PCR was performed using RNA extracted from liver samples of 40 pigs. The second reaction was expected to produce a 266 bp product (Fig. 4). Swine HEV nucleic acids were detected in 22 liver samples (55%) out of the 40 pigs examined, but not in negative control pigs. Of these, swine HEV RNA was detected in 54.5% suckling pigs (18 cases) and 57.1% growing pigs (4 cases). Based on the PCR results, swine HEV positive piglets were distributed across 5 counties, Hallim (10/15), Hangyeong (1/2), Daejeong (7/15), Namwon (2/2) and Pyoseon (2/4) in Jeju Island. Seventeen cases of swine HEV positive piglets were concentrated in the counties of Hallim and Daejeong, western part of Jeju Island.

Discussion

HEV infection in pigs appears to be widespread throughout the world. Antibodies to HEV have been identified in pigs from countries where HEV is endemic, such as Nepal, China, and Thailand, and many industrialized countries, including the US, Canada, Korea, Japan, Taiwan, and Australia [3,5,10,15]. In the present study, swine HEV RNA was detected in 55% of pig livers with hepatitis lesions from different herds, indicating that infection is prevalent in different areas of Jeju Island. In a previous experiment, 3 swine HEV cases were identified out of a total of 128 pig sera collected from 10 pig herds, signifying a 2.3% rate of HEV viremia prevalence in the Korean Peninsula [4]. The overall prevalence of anti-swine HEV antibodies in pigs was approximately 14.8%. The prevalence of HEV RNA among 2-month-old domestic pigs in swine farms in various Asian countries was 2.7% in Japan [20], 1.6% in Korea [4], and 4.5% in Taiwan [26]. Considering all the different samples and methods applied, HEV infection was consistently more prevalent in pigs raised in Jeju Island than in those from the Korean Peninsula. It is evident from our data that swine HEV infection occurs at a very young age (under 2 months) in Jeju pigs. The precise natural route of HEV transmission in pigs remains to be established. Swine HEV can be transmitted experimentally via direct contact with infected pigs [16]. In fact, a recent study revealed successful experimental transmission of HEV in pigs by the fecal-to-oral route, similar to that in humans [11]. Efficient transmission of swine HEV in pigs via the fecal-oral route may require repeated exposure and high doses. Swine HEV viremia is transient, and lasts only 1 to 2 weeks, whereas fecal virus shedding may persist up to 7 weeks [8,16]. Thus, HEV in sick commercial pigs is potentially infectious to other pigs in same herds. Moreover, HEV is widespread in the general swine population in Jeju. However, naturally infected pigs did not display any clinical signs associated with HEV, although there was histopathological evidence of hepatitis, suggesting that swine HEV only caused subclinical infection in pigs in Jeju Island.
According to a previous study, various hepatitis virus antigens have been detected in liver tissue by immunohistochemical techniques [7]. However, these viral markers are only transiently expressed during the incubation and early symptomatic periods of acute viral hepatitis and may not be present during active disease, since the virus is rapidly eliminated. Therefore, immunohistochemistry is not particularly useful in the diagnosis of acute viral hepatitis, particularly since reliable serologic or molecular tests are generally available. Therefore the PCR method might be more sensitive, and thus more applicable as a specific assay for the diagnosis of various infectious diseases, compared to immunohistochemistry.
The zoonotic potential of swine HEV, based on experimental, molecular virological and epidemiological evidence, is a subject of considerable concern in many countries. All 11 pig handlers tested in China were positive for anti-HEV IgG, along with 17 (55%) of 31 apparently healthy blood donors in the same geographical region [15]. In Taiwan, 27% of the pig handlers tested positive for anti-HEV IgG, whereas only about 8% of the control subjects were seropositive [10]. In the US, the prevalence of HEV infection among North Carolina swine workers (11%) was 4.5-fold higher than that among non-swine workers (2.4%) [24]. There was a difference in anti-HEV prevalence in both swine veterinarians and blood donors among the eight selected states. Subjects from Minnesota (a major pork-producing state) were six times more likely to be anti-HEV positive than those from Alabama [19]. These findings clearly indicate that many people associated with the pig industry and researchers using pigs as experimental animals are at risk for zoonotic HEV infection. One case of hepatitis E in Korea was related to travel to a region of an HEV endemic country, India [12]. Recently, 9 cases of sporadic HEV infection were observed in Korea, without any evidence of contact with pigs [13]. Due to the relative high prevalence of swine HEV in Jeju Island, more swine practitioners and veterinarians are at increased potential risk of HEV infection within this region, compared to the Korean Peninsula.
Pigs are currently the preferable species for xenotransplantation, despite their dissimilarity to humans [14]. However, transmission of xenozoonotic pathogens from pigs to human recipient is a major problem in xenotransplantation. While swine HEV appears to be subclinical for pigs and humans in natural or experimental infections, it may become pathogenic in immunocompromised recipients of xenotransplantation. In our experiments, pigs infected with swine HEV displayed histopathological lesions of the liver. Due to the transmission of HEV from pigs to human recipients, the livers of swine HEV-infected pigs have limitations for use in xenotransplantation. Therefore, the development of a sensitive and accurate screening technology for swine HEV in donor pigs is necessary.
In summary, swine HEV nucleic acid was detected in 22 out of 40 porcine liver tissues with hepatitis. Of these, HEV was observed in 54.5% suckling pigs (18 cases) and 57.1% growing pigs (4 cases). The high prevalence of swine HEV in pigs in Jeju Island and the ability of the virus to infect across species puts individuals with swine-associated occupations at possible risk of zoonotic infection.

Figures and Tables

Fig. 1
Liver of swine HEV positive pig with scattered yellowish discoloration foci (white arrows).
jvs-8-51-g001
Fig. 2
Liver of swine HEV positive pig with mild lymphoplasmacytic infiltration in hepatic sinusoids and portal triad. H&E stain. × 100.
jvs-8-51-g002
Fig. 3
Liver of swine HEV positive pig. There is severe lymphoplasmacytic hepatitis in sinusoid and peri-portal area. H&E stain. × 200.
jvs-8-51-g003
Fig. 4
Nested PCR products of swine HEV from liver homogenate. Lane M: 100 bp DNA ladder; lane 1-4: 266 bp field samples; lane 5: SHEV positive control; lane 6: SHEV negative control.
jvs-8-51-g004

Acknowledgments

This work was supported by the Research Project on the Production of Bio-organs (No. 200503010403), Ministry of Agriculture and Forestry, Korea.

References

1. Ahn JM, Kang SG, Lee DY, Shin SJ, Yoo HS. Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea. J Clin Mirobiol. 2005. 43:3042–3048.
crossref
2. Anderson DA, Cheng RH. Thomas HC, Lemon SM, Zuckerman AJ, editors. Hepatitis E virus: structure and molecular virology. Viral Hepatitis. 2005. 3rd ed. Malden: Blackwell Publishing;603–610.
3. Chandler JD, Riddell MA, Li F, Love RJ, Anderson DA. Serological evidence of swine hepatitis E virus infection in Australian pig herds. Vet Microbiol. 1999. 68:95–105.
crossref
4. Choi IS, Kwon HJ, Shin HR, Yoo HS. Identification of swine hepatitis E virus (HEV) and prevalence of anti-HEV antibodies in swine and human population in Korea. J Clin Microbiol. 2003. 41:3602–3608.
crossref
5. Clayson ET, Innis BL, Myint KS, Narupiti S, Vaughn DW, Giri S, Ranabhat P, Shrestha MP. Detection of hepatitis E virus infections among domestic swine in the Kathmandu valley of Nepal. Am J Trop Med Hyg. 1995. 53:228–232.
crossref
6. Garkavenko O, Obriadina A, Meng J, Anderson DA, Benard HJ, Schroeder BA, Khudyakov YE, Fields HA, Croxson MC. Detection and characterization of swine hepatitis E virus in New Zealand. J Med Virol. 2001. 65:525–529.
crossref
7. Ha SK, Chae C. Immunohistochemistry for the detection of swine hepatitis E virus in the liver. J Viral Hepat. 2004. 11:263–267.
crossref
8. Halbur PG, Kasorndorkbua C, Gilbert C, Guenette D, Potters MB, Purcell RH, Emerson SU, Toth TE, Meng XJ. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol. 2001. 39:918–923.
crossref
9. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. J Viral Hepat. 1997. 4:51–54.
crossref
10. Hsieh SY, Meng XJ, Wu YH, Liu ST, Tam AW, Lin DY, Liaw YF. Identify of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus. J Clin Microbiol. 1999. 37:3828–3834.
crossref
11. Kasorndorkbua C, Guenette DK, Huang FF, Thomas PJ, Meng XJ, Halbur PG. Routes of transmission of swine hepatitis E virus in pigs. J Clin Microbiol. 2004. 42:5047–5052.
crossref
12. Kim SS, Yeo CD, Kim JD, Kim HS, Jang JW, Kim CW, Bae SH, Choi JY, Yoon SK. A case of acute hepatitis E with the travel history to an endemic area. Korean J Gastroenterol. 2004. 44:342–345.
13. Lim JW, Park CS, Ahn JM, Yu MH, Kim TS, Lim YS, Chung SW, Kim GM, Chung YH, Lee YS, Suh DJ. Nine cases of sporadic acute hepatitis E in Korea. Korean J Hepatol. 2006. 12:230–236.
14. Magre S, Takeuchi Y, Bartosch B. Xenotransplantation and pig endogenous retroviruses. Rev Med Virol. 2003. 13:311–329.
crossref
15. Meng XJ, Dea S, Engle RE, Friendship R, Lyoo YS, Sirinarumitr T, Urairong K, Wang D, Wong D, Yoo D, Zhang Y, Purcell RH, Emerson SU. Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population. J Med Virol. 1999. 59:297–302.
crossref
16. Meng XJ, Halbur PG, Haynes JS, Tsareva TS, Bruna JD, Royer RL, Purcell RH, Emerson SU. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol. 1998. 143:1405–1415.
crossref
17. Meng XJ, Halbur PG, Shapiro MS, Govindarajan S, Bruna JD, Mushahwar IK, Purcell RH, Emerson SU. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol. 1998. 72:9714–9721.
crossref
18. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, Haynes JS, Thacker BJ, Emerson SU. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA. 1997. 94:9860–9865.
crossref
19. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002. 40:117–122.
crossref
20. Okamoto H, Takahashi M, Nishizawa T, Fukai K, Muramatsu U, Yoshikawa A. Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem Biophys Res Commun. 2001. 289:929–936.
crossref
21. Purcell RH, Emerson SU. Knipe DM, Howley PM, editors. Hepatitis E virus. Fields' Virology. 2001. 4th ed. Philadelphia: Lippincott Williams & Wilkins;3051–3061.
22. Takahashi M, Nishizawa T, Miyajima H, Gotanda Y, Iita T, Tsuda F, Okamoto H. Swine hepatitis E virus strains in Japan from four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol. 2003. 84:851–862.
crossref
23. van der Poel WHM, Verschoor F, van der Heide R, Herrera MI, Vivo A, Kooreman M, de Roda Husman AM. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg Infect Dis. 2001. 7:970–976.
crossref
24. Withers MR, Correa MT, Morrow M, Stebbins ME, Seriwatana J, Webster WD, Boak MB, Vaughn DW. Antibody levels to hepatitis E virus in North Carolina swine workers, non-swine workers, swine, and murids. Am J Trop Med Hyg. 2002. 66:384–388.
crossref
25. Wu JC, Chen CM, Chiang TY, Sheen IJ, Chen JY, Tsai WH, Huang YH, Lee SD. Clinical and epidemiological implications of swine hepatitis E virus infection. J Med Virol. 2000. 60:166–171.
crossref
26. Wu JC, Chen CM, Chiang TY, Tsai WH, Jeng WJ, Sheen IJ, Lin CC, Meng XJ. Spread of hepatitis E virus among different-aged pigs: two-year survey in Taiwan. J Med Virol. 2002. 66:488–492.
crossref
27. Yoo D, Willson P, Pei Y, Hayes MA, Deckert A, Dewey CE, Friendship RM, Yoon Y, Gottschalk M, Yason C, Giulivi A. Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus. Clin Diagn Lab Immunol. 2001. 8:1213–1219.
crossref
TOOLS
Similar articles